These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 23233643)
21. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP. Cataland SR; Holers VM; Geyer S; Yang S; Wu HM Blood; 2014 Jun; 123(24):3733-8. PubMed ID: 24695849 [TBL] [Abstract][Full Text] [Related]
22. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report. Sengul Samanci N; Ayer M; Ergen A; Ozturk S Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788 [TBL] [Abstract][Full Text] [Related]
23. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea. Cheong HI; Jo SK; Yoon SS; Cho H; Kim JS; Kim YO; Koo JR; Park Y; Park YS; Shin JI; Yoo KH; Oh D J Korean Med Sci; 2016 Oct; 31(10):1516-28. PubMed ID: 27550478 [TBL] [Abstract][Full Text] [Related]
24. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement. Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580 [TBL] [Abstract][Full Text] [Related]
25. Atypical hemolytic-uremic syndrome: a case report and literature review. Rafiq A; Tariq H; Abbas N; Shenoy R Am J Case Rep; 2015 Feb; 16():109-14. PubMed ID: 25708146 [TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry. Halimi JM; Al-Dakkak I; Anokhina K; Ardissino G; Licht C; Lim WH; Massart A; Schaefer F; Walle JV; Rondeau E J Nephrol; 2023 Apr; 36(3):817-828. PubMed ID: 36152218 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future. Risitano AM; Marotta S Semin Immunol; 2016 Jun; 28(3):223-40. PubMed ID: 27346521 [TBL] [Abstract][Full Text] [Related]
29. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome. Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055 [TBL] [Abstract][Full Text] [Related]
30. Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure-A Rare Presentation: Diagnosis Supported by Skin Biopsy. Kichloo A; Chugh SS; Gupta S; Pandav J; Chander P J Investig Med High Impact Case Rep; 2019; 7():2324709619842905. PubMed ID: 31010328 [TBL] [Abstract][Full Text] [Related]
31. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome. Lee H; Kang E; Kang HG; Kim YH; Kim JS; Kim HJ; Moon KC; Ban TH; Oh SW; Jo SK; Cho H; Choi BS; Hong J; Cheong HI; Oh D Korean J Intern Med; 2020 Jan; 35(1):25-40. PubMed ID: 31935318 [TBL] [Abstract][Full Text] [Related]
32. [Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy]. Yurova VA; Kozlovskaya NL; Bobrova LA; Kozlov LV; Andina SS; Demyanova KA Ter Arkh; 2023 Aug; 95(6):475-480. PubMed ID: 38158966 [TBL] [Abstract][Full Text] [Related]